SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-011039
Filing Date
2017-05-15
Accepted
2017-05-15 16:22:21
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20170331.htm 10-Q 671677
2 EX-10.3 evok-ex103_193.htm EX-10.3 25593
3 EX-31.1 evok-ex311_192.htm EX-31.1 9581
4 EX-31.2 evok-ex312_191.htm EX-31.2 9863
5 EX-32.1 evok-ex321_190.htm EX-32.1 5023
6 EX-32.2 evok-ex322_189.htm EX-32.2 5240
  Complete submission text file 0001564590-17-011039.txt   2923021

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT evok-20170331.xml EX-101.INS 508811
8 XBRL TAXONOMY EXTENSION SCHEMA evok-20170331.xsd EX-101.SCH 31786
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20170331_cal.xml EX-101.CAL 16376
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20170331_def.xml EX-101.DEF 116504
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20170331_lab.xml EX-101.LAB 229809
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20170331_pre.xml EX-101.PRE 180698
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 17844522
SIC: 2834 Pharmaceutical Preparations